Petros Pharmaceuticals (PTPI) Short Interest Ratio & Short Volume $0.25 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Petros Pharmaceuticals Short Interest DataPetros Pharmaceuticals (PTPI) has a short interest of 199,200 shares, representing 2.19% of the float (the number of shares available for trading by the public). This marks a -27.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 519,343 shares to cover all short positions.Current Short Interest199,200 sharesPrevious Short Interest273,600 sharesChange Vs. Previous Month-27.19%Dollar Volume Sold Short$73,704.00Short Interest Ratio1.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares10,020,000 sharesFloat Size9,080,000 sharesShort Percent of Float2.19%Today's Trading Volume226,844 sharesAverage Trading Volume519,343 sharesToday's Volume Vs. Average44% Short Selling Petros Pharmaceuticals? Sign up to receive the latest short interest report for Petros Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPTPI Short Interest Over TimePTPI Days to Cover Over TimePTPI Percentage of Float Shorted Over Time Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Petros Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024199,200 shares $73,704.00 -27.2%2.2%1.2 $0.37 10/15/2024273,600 shares $83,393.28 -7.2%3.1%1.4 $0.30 9/30/2024294,900 shares $105,279.30 +25.4%3.4%1.3 $0.36 9/15/2024235,100 shares $85,650.93 -20.6%2.7%0.8 $0.36 8/31/2024295,900 shares $98,445.93 +13.5%3.5%0.8 $0.33 8/15/2024260,700 shares $86,969.52 -40.0%3.1%0.6 $0.33 Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024434,200 shares $176,285.20 +69.9%7.1%1 $0.41 7/15/2024255,500 shares $115,997.00 -28.5%4.2%0.6 $0.45 6/30/2024357,200 shares $163,419.00 -23.7%5.8%1 $0.46 6/15/2024468,300 shares $194,578.65 +202.3%7.7%1 $0.42 5/31/2024154,900 shares $95,139.58 +82.9%2.5%0.3 $0.61 5/15/202484,700 shares $43,671.32 -37.0%1.4%0.1 $0.52 4/30/2024134,500 shares $88,299.25 +92.7%3.3%0.2 $0.66 4/15/202469,800 shares $54,660.38 -52.3%1.7%0.1 $0.78 3/31/2024146,200 shares $216,376.00 +65.4%3.6%0.1 $1.48 3/15/202488,400 shares $134,368.00 -72.1%6.8%0.1 $1.52 2/29/2024317,200 shares $545,584.00 +12.3%24.2%0.3 $1.72 2/15/2024282,400 shares $434,896.00 +16.5%21.9%0.3 $1.54 1/31/2024242,400 shares $293,304.00 +2,208.6%18.8%0.4 $1.21 1/15/202410,500 shares $13,807.50 -74.8%0.8%0 $1.32 12/31/202341,700 shares $58,797.00 -66.5%3.1%0.2 $1.41 12/15/2023124,300 shares $172,777.00 +571.9%9.1%0.6 $1.39 11/30/202318,500 shares $29,600.00 -28.3%1.4%0.2 $1.60 11/15/202325,800 shares $34,314.00 -41.6%2.0%0.8 $1.33 10/31/202344,200 shares $63,206.00 -27.9%3.5%1.3 $1.43 10/15/202361,300 shares $98,073.87 +415.1%4.9%1.4 $1.60 9/30/202311,900 shares $20,585.81 +213.2%0.9%0 $1.73 9/15/20233,800 shares $6,878.00 -82.3%0.3%0 $1.81 8/31/202321,500 shares $54,825.00 -62.7%1.7%0.1 $2.55 8/15/202357,700 shares $184,640.00 -21.9%3.9%0.2 $3.20 7/31/202373,900 shares $296,339.00 -79.4%5.0%0.2 $4.01 7/15/2023359,100 shares $1.14 million +1,330.7%24.3%0.5 $3.19 6/30/202325,100 shares $50,953.00 -27.0%1.7%0 $2.03 6/15/202334,400 shares $89,784.00 -10.7%2.3%0 $2.61 5/31/202338,500 shares $89,705.00 -13.5%2.6%0 $2.33 5/15/202344,500 shares $186,900.00 -88.5%3.0%0 $4.20 4/30/2023385,300 shares $1.66 million +1,029.9%27.3%0.2 $4.30 4/15/202334,100 shares $156,519.00 -22.5%2.4%0 $4.59 3/31/202344,000 shares $61,380.00 +14.9%3.1%3.1 $1.40 3/15/202338,300 shares $56,684.00 +13.0%2.7%2.1 $1.48JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/28/202333,900 shares $71,190.00 -6.6%2.4%1.6 $2.10 2/15/202336,300 shares $92,202.00 +23.1%2.5%1.8 $2.54 1/31/202329,500 shares $76,700.00 -24.4%2.1%1.5 $2.60 1/15/202339,000 shares $118,950.00 +14.0%2.7%1.6 $3.05 12/30/202234,200 shares $79,686.00 +14.8%2.4%1.4 $2.33 12/15/202229,800 shares $63,176.00 +43.3%2.1%1.8 $2.12 11/30/202220,800 shares $8,550.88 -92.2%1.4%1.5 $0.41 11/15/2022265,700 shares $130,193.00 +78.6%N/A2.1 $0.49 10/31/2022148,800 shares $71,424.00 +9.3%N/A1 $0.48 10/15/2022136,200 shares $58,525.14 +77.3%N/A0.2 $0.43 9/30/202276,800 shares $39,168.00 -36.1%N/A0.1 $0.51 9/15/2022120,200 shares $78,682.92 -7.1%N/A0.1 $0.65 8/31/2022129,400 shares $84,821.70 +45.4%N/A0.1 $0.66 8/15/202289,000 shares $71,627.20 +420.5%N/A0.1 $0.80 7/31/202217,100 shares $13,573.98 -22.3%N/A0 $0.79 7/15/202222,000 shares $18,099.40 -56.2%N/A0.1 $0.82 6/30/202250,200 shares $42,157.96 +46.8%N/A0 $0.84 6/15/202234,200 shares $26,744.40 -81.0%N/A0 $0.78 5/31/2022179,500 shares $174,976.60 +89.2%N/A0.1 $0.97 5/15/202294,900 shares $91,113.49 -30.0%N/A0.1 $0.96 4/30/2022135,600 shares $153,228.00 -26.0%N/A0.1 $1.13 4/15/2022183,300 shares $221,793.00 -39.8%N/A0.1 $1.21 3/31/2022304,400 shares $474,864.00 +15.1%N/A0.4 $1.56 3/15/2022264,500 shares $285,660.00 -39.7%N/A0.1 $1.08 2/28/2022438,900 shares $605,682.00 -38.5%N/A0.1 $1.38 2/15/2022714,000 shares $1.14 million -15.3%N/A0.1 $1.59 1/31/2022842,700 shares $1.46 million -54.9%N/A0.1 $1.73 1/15/20221,870,000 shares $4.90 million -19.7%N/A0.1 $2.62 12/31/20212,330,000 shares $7.76 million -22.9%28.1%0.1 $3.33 12/15/20213,020,000 shares $8.67 million +41.1%35.7%0.2 $2.87 11/30/20212,140,000 shares $6.12 million +459.6%55.9%0.2 $2.86 11/15/2021382,400 shares $833,632.00 +359.6%8.9%0.1 $2.18 10/29/202183,200 shares $144,768.00 -22.2%2.6%0 $1.74 10/15/2021106,900 shares $175,316.00 +20.0%1.8%1.2 $1.64 9/30/202189,100 shares $178,200.00 -22.9%1.5%1.6 $2.00 9/15/2021115,600 shares $239,292.00 -20.8%1.9%2.1 $2.07 8/31/2021145,900 shares $328,275.00 -16.1%2.4%1.8 $2.25 8/13/2021173,900 shares $525,178.00 -9.1%2.8%1.7 $3.02 7/30/2021191,200 shares $581,248.00 +19.3%3.1%0.9 $3.04 7/15/2021160,300 shares $488,915.00 +18.3%2.6%0.8 $3.05 6/30/2021135,500 shares $424,115.00 +21.1%2.2%0.7 $3.13 6/15/2021111,900 shares $349,128.00 +105.0%1.8%0.5 $3.12 5/28/202154,600 shares $165,438.00 -1.1%0.9%0.3 $3.03 5/14/202155,200 shares $162,840.00 -18.9%0.9%0.3 $2.95 4/30/202168,100 shares $224,730.00 +6.2%1.1%1.4 $3.30 4/15/202164,100 shares $201,915.00 -19.0%1.0%0.8 $3.15 3/31/202179,100 shares $288,715.00 +4.2%1.3%0.9 $3.65 3/15/202175,900 shares $256,542.00 +20.5%1.2%0.5 $3.38 2/26/202163,000 shares $218,610.00 -9.1%1.0%0.4 $3.47 2/12/202169,300 shares $293,832.00 +234.8%1.1%0.4 $4.24JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/29/202120,700 shares $70,173.00 +269.6%0.3%0.1 $3.39 1/15/20215,600 shares $24,136.00 No ChangeN/A0 $4.31 PTPI Short Interest - Frequently Asked Questions What is Petros Pharmaceuticals' current short interest? Short interest is the volume of Petros Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 199,200 shares of PTPI short. 2.19% of Petros Pharmaceuticals' shares are currently sold short. Learn More on Petros Pharmaceuticals' current short interest. What is a good short interest ratio for Petros Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTPI shares currently have a short interest ratio of 1.0. Learn More on Petros Pharmaceuticals's short interest ratio. What is a good short interest percentage for Petros Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.19% of Petros Pharmaceuticals' floating shares are currently sold short. Is Petros Pharmaceuticals' short interest increasing or decreasing? Petros Pharmaceuticals saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 199,200 shares, a decline of 27.2% from the previous total of 273,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Petros Pharmaceuticals' float size? Petros Pharmaceuticals currently has issued a total of 10,020,000 shares. Some of Petros Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Petros Pharmaceuticals currently has a public float of 9,080,000 shares. How does Petros Pharmaceuticals' short interest compare to its competitors? 2.19% of Petros Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Petros Pharmaceuticals: Trinity Biotech plc (0.86%), Onconetix, Inc. (0.62%), Eagle Pharmaceuticals, Inc. (2.90%), Aytu BioPharma, Inc. (3.24%), Vincerx Pharma, Inc. (2.42%), Jaguar Health, Inc. (4.31%), RedHill Biopharma Ltd. (0.13%), Soligenix, Inc. (2.07%), Addex Therapeutics Ltd (0.43%), Moleculin Biotech, Inc. (4.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Petros Pharmaceuticals stock? Short selling PTPI is an investing strategy that aims to generate trading profit from Petros Pharmaceuticals as its price is falling. PTPI shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Petros Pharmaceuticals? A short squeeze for Petros Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PTPI, which in turn drives the price of the stock up even further. How often is Petros Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTPI, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Mustang Bio Short Squeeze Kiora Pharmaceuticals Short Squeeze Trinity Biotech Short Squeeze Conduit Pharmaceuticals Short Squeeze Senti Biosciences Short Squeeze Onconetix Short Squeeze Aytu BioPharma Short Squeeze Jaguar Health Short Squeeze Addex Therapeutics Short Squeeze RedHill Biopharma Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTPI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
